Spectra for:
Tomoki Maruta, Takeshi Saito, Masanori Inagaki, Osamu Shibata, Ryuichi Higuchi
Compound LLC-2 MAJOR-NORMAL-CHAIN
Compound LLC-2 MAJOR-ISO-CHAIN
Compound LLC-2 MAJOR-ANTE-ISO-CHAIN
Compound 1 1-O-(BETA-D-GLUCOPYRANOSYL)-(2S,3S,4R)-2-[(2R)-2-HYDROXYHEXADECANOYLAMINO]-16-METHYL-HEPTADECANE-1,3,4-TRIOL;LLC-2-1
![1-O-(BETA-D-GLUCOPYRANOSYL)-(2S,3S,4R)-2-[(2R)-2-HYDROXYHEXADECANOYLAMINO]-16-METHYL-HEPTADECANE-1,3,4-TRIOL;LLC-2-1](/api/compound/8CevwyFOtY2.png?h=300&w=458 "1-O-(BETA-D-GLUCOPYRANOSYL)-(2S,3S,4R)-2-[(2R)-2-HYDROXYHEXADECANOYLAMINO]-16-METHYL-HEPTADECANE-1,3,4-TRIOL;LLC-2-1")
Compound 3 LLC-2-10
Compound 4 LLC-2-12
Compound 5 LLC-2-15
SYNTHETIC-CEREBROSIDE
Citation
| Citation | CHEM.PHARM.BULL.,53,1255(2005) |
|---|---|
| Journal | Chemical and Pharmaceutical Bulletin |
| Issue | 10 |
| Volume | 53 |
| Page(s) | 1255-1258 |
| Year | 2005 |
| Author(s) | Tomoki Maruta, Takeshi Saito, Masanori Inagaki, Osamu Shibata, Ryuichi Higuchi |
| Publisher | Pharmaceutical Society of Japan |
| DOI | 10.1248/cpb.53.1255 |